Yanfei Xia

1.1k total citations · 1 hit paper
19 papers, 876 citations indexed

About

Yanfei Xia is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Surgery. According to data from OpenAlex, Yanfei Xia has authored 19 papers receiving a total of 876 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 6 papers in Cardiology and Cardiovascular Medicine and 5 papers in Surgery. Recurrent topics in Yanfei Xia's work include MicroRNA in disease regulation (3 papers), Inflammasome and immune disorders (3 papers) and Anesthesia and Sedative Agents (3 papers). Yanfei Xia is often cited by papers focused on MicroRNA in disease regulation (3 papers), Inflammasome and immune disorders (3 papers) and Anesthesia and Sedative Agents (3 papers). Yanfei Xia collaborates with scholars based in China, United States and Japan. Yanfei Xia's co-authors include Fengshuang An, Cheng Zhang, Mingxiang Zhang, Beibei Luo, Yun Zhang, Xiangjuan Liu, Bo Li, Wenke Wang, Xiaoman Liu and Bo Li and has published in prestigious journals such as PLoS ONE, Scientific Reports and Biochemical and Biophysical Research Communications.

In The Last Decade

Yanfei Xia

19 papers receiving 867 citations

Hit Papers

NLRP3 Gene Silencing Ameliorates Diabetic Cardiomyopathy ... 2014 2026 2018 2022 2014 100 200 300

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yanfei Xia China 15 504 243 176 126 108 19 876
Junsong Gong United States 17 643 1.3× 85 0.3× 99 0.6× 108 0.9× 71 0.7× 27 1.3k
Minmin Zhu China 21 496 1.0× 77 0.3× 121 0.7× 216 1.7× 104 1.0× 52 1.2k
Zhihao Wang China 19 690 1.4× 270 1.1× 154 0.9× 282 2.2× 193 1.8× 71 1.3k
Lefeng Wang China 16 208 0.4× 187 0.8× 135 0.8× 65 0.5× 96 0.9× 52 746
Zhen Qiu China 14 784 1.6× 125 0.5× 146 0.8× 195 1.5× 152 1.4× 38 1.2k
Ying Tong China 17 496 1.0× 141 0.6× 128 0.7× 131 1.0× 83 0.8× 34 928
Yu Zhu China 21 609 1.2× 106 0.4× 129 0.7× 142 1.1× 314 2.9× 79 1.3k
Stuart J. Netherton Canada 20 825 1.6× 243 1.0× 154 0.9× 78 0.6× 61 0.6× 33 1.3k
Zhenhong Fu China 14 323 0.6× 210 0.9× 134 0.8× 77 0.6× 163 1.5× 30 850

Countries citing papers authored by Yanfei Xia

Since Specialization
Citations

This map shows the geographic impact of Yanfei Xia's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yanfei Xia with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yanfei Xia more than expected).

Fields of papers citing papers by Yanfei Xia

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yanfei Xia. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yanfei Xia. The network helps show where Yanfei Xia may publish in the future.

Co-authorship network of co-authors of Yanfei Xia

This figure shows the co-authorship network connecting the top 25 collaborators of Yanfei Xia. A scholar is included among the top collaborators of Yanfei Xia based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yanfei Xia. Yanfei Xia is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
2.
Xia, Yanfei, et al.. (2022). Analgesic Effect of Ropivacaine Combined with Hydromorphone following Surgery for Mixed Hemorrhoids: A Pilot Study. Pain Research and Management. 2022. 1–6. 6 indexed citations
3.
Wang, Lei, et al.. (2020). Repositioning Lidocaine as an Anticancer Drug: The Role Beyond Anesthesia. Frontiers in Cell and Developmental Biology. 8. 565–565. 31 indexed citations
4.
Shang, Jian, et al.. (2020). MiR-27a-3p overexpression mitigates inflammation and apoptosis of lipopolysaccharides-induced alveolar epithelial cells by targeting FOXO3 and suppressing the activation of NAPDH/ROS. Biochemical and Biophysical Research Communications. 533(4). 723–731. 17 indexed citations
5.
Jin, Xin, et al.. (2019). Function and mechanism of pyrin and IL‑10 in the regulation of the inflammasome in pulmonary vascular endothelial cells following hemorrhagic shock. Experimental and Therapeutic Medicine. 18(3). 1768–1774. 1 indexed citations
7.
Lü, Xing, et al.. (2017). The correlation of the depth of anesthesia and postoperative cognitive impairment: A meta-analysis based on randomized controlled trials. Journal of Clinical Anesthesia. 45. 55–59. 45 indexed citations
8.
Wang, Hongmei, et al.. (2017). Comparison of dexmedetomidine and propofol for conscious sedation in inguinal hernia repair: A prospective, randomized, controlled trial. Journal of International Medical Research. 45(2). 533–539. 17 indexed citations
9.
Liu, Hui, Yanfei Xia, Beibei Li, et al.. (2016). Prolyl hydroxylase 3 overexpression accelerates the progression of atherosclerosis in ApoE−/− mice. Biochemical and Biophysical Research Communications. 473(1). 99–106. 14 indexed citations
10.
Li, Rui, Hai-Hua Geng, Jie Xiao, et al.. (2016). miR-7a/b attenuates post-myocardial infarction remodeling and protects H9c2 cardiomyoblast against hypoxia-induced apoptosis involving Sp1 and PARP-1. Scientific Reports. 6(1). 29082–29082. 67 indexed citations
11.
Xia, Yanfei, Hui Liu, Beibei Luo, et al.. (2015). Inhibition of prolyl hydroxylase 3 ameliorates cardiac dysfunction in diabetic cardiomyopathy. Molecular and Cellular Endocrinology. 403. 21–29. 23 indexed citations
12.
Xia, Yanfei, et al.. (2015). The role of TNF-α in regulating ketamine-induced hippocampal neurotoxicity. Archives of Medical Science. 6(6). 1296–1302. 24 indexed citations
13.
Lv, Mei, Yanfei Xia, Bo Li, et al.. (2015). Serum amyloid A stimulates vascular endothelial growth factor receptor 2 expression and angiogenesis. Journal of Physiology and Biochemistry. 72(1). 71–81. 28 indexed citations
14.
Li, Rui, Jie Xiao, Junhui Xing, et al.. (2015). Sp1 Mediates a Therapeutic Role of MiR-7a/b in Angiotensin II-Induced Cardiac Fibrosis via Mechanism Involving the TGF-β and MAPKs Pathways in Cardiac Fibroblasts. PLoS ONE. 10(4). e0125513–e0125513. 29 indexed citations
15.
Luo, Beibei, Bo Li, Wenke Wang, et al.. (2014). NLRP3 Gene Silencing Ameliorates Diabetic Cardiomyopathy in a Type 2 Diabetes Rat Model. PLoS ONE. 9(8). e104771–e104771. 356 indexed citations breakdown →
16.
Li, Bo, Zhe Dong, Hui Liu, et al.. (2013). Serum amyloid A stimulates lipoprotein-associated phospholipase A2 expression in vitro and in vivo. Atherosclerosis. 228(2). 370–379. 23 indexed citations
17.
Luo, Beibei, Bo Li, Wenke Wang, et al.. (2013). Rosuvastatin Alleviates Diabetic Cardiomyopathy by Inhibiting NLRP3 Inflammasome and MAPK Pathways in a Type 2 Diabetes Rat Model. Cardiovascular Drugs and Therapy. 28(1). 33–43. 132 indexed citations
18.
Liu, Xiaoman, Bo Li, Wenke Wang, et al.. (2012). Effects of HMG-CoA Reductase Inhibitor on Experimental Autoimmune Myocarditis. Cardiovascular Drugs and Therapy. 26(2). 121–130. 22 indexed citations
19.
Xia, Yanfei, et al.. (2001). DNA damage in buccal epithelial cells from individuals chronically exposed to arsenic via drinking water in Inner Mongolia, China.. PubMed. 21(1A). 51–7. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026